Skip to content

RNTX RNTX Operating Cash Flow

Operating Cash Flow at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$1.1B-43.5%
Gilead Sciences logo
Gilead SciencesGILD
$2.54B+44.8%
AbbVie logo
AbbVieABBV
$3.83B+134%
CTO
Citius Oncology, Inc.CTOR
-$3.83M-179%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
-$12.52M+18.8%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$3.18M+2,565%

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+177%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Reported directly by RNTX in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's operating cash flow?
RNTX (RNTX) reported operating cash flow of -$3.42M in Q1 2026.
How has RNTX's operating cash flow changed year-over-year?
RNTX's operating cash flow increased by 44.6% year-over-year, from -$6.18M to -$3.42M.
What is the long-term trend for RNTX's operating cash flow?
Over 4 years (2021 to 2025), RNTX's operating cash flow has grown at a -5.0% compound annual growth rate (CAGR), from -$23.75M to -$19.36M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.